{"product_id":"vilon-5mg-vial","title":"Vilon 20mg vial","description":"\u003cp data-start=\"373\" data-end=\"863\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                              \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN \u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003eCONSUMPTION\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"373\" data-end=\"863\"\u003e\u003cstrong data-start=\"373\" data-end=\"382\"\u003eVilon\u003c\/strong\u003e is a synthetic dipeptide consisting of \u003cstrong data-start=\"422\" data-end=\"454\"\u003eL-lysine and L-glutamic acid\u003c\/strong\u003e (Lys-Glu), developed by the \u003cstrong data-start=\"483\" data-end=\"544\"\u003eSt. Petersburg Institute of Bioregulation and Gerontology\u003c\/strong\u003e as part of a class of short peptides known as \u003cstrong data-start=\"591\" data-end=\"605\"\u003ecytomedins\u003c\/strong\u003e or \u003cstrong data-start=\"609\" data-end=\"634\"\u003epeptide bioregulators\u003c\/strong\u003e. These compounds are designed to mimic naturally occurring regulatory peptides extracted from mammalian tissues and are proposed to \u003cstrong data-start=\"767\" data-end=\"795\"\u003emodulate gene expression\u003c\/strong\u003e, \u003cstrong data-start=\"797\" data-end=\"830\"\u003emaintain cellular homeostasis\u003c\/strong\u003e, and \u003cstrong data-start=\"836\" data-end=\"862\"\u003edelay organismal aging\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"865\" data-end=\"1139\"\u003eVilon, specifically, has been primarily studied for its \u003cstrong data-start=\"921\" data-end=\"941\"\u003eimmunomodulatory\u003c\/strong\u003e, \u003cstrong data-start=\"943\" data-end=\"961\"\u003egeroprotective\u003c\/strong\u003e, and \u003cstrong data-start=\"967\" data-end=\"981\"\u003eoncostatic\u003c\/strong\u003e effects. It is commonly categorized as an \u003cstrong data-start=\"1024\" data-end=\"1041\"\u003eimmunopeptide\u003c\/strong\u003e, due to its targeted activity on \u003cstrong data-start=\"1075\" data-end=\"1092\"\u003ethymic tissue\u003c\/strong\u003e, T-lymphocytes, and the broader immune system.\u003c\/p\u003e\n\u003chr data-start=\"1141\" data-end=\"1144\"\u003e\n\u003ch2 data-start=\"1146\" data-end=\"1185\"\u003e\u003cstrong data-start=\"1149\" data-end=\"1185\"\u003e2. Molecular Mechanism of Action\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-start=\"1187\" data-end=\"1242\"\u003e\u003cstrong data-start=\"1191\" data-end=\"1242\"\u003e2.1. Nuclear Signaling and Chromatin Remodeling\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1244\" data-end=\"1547\"\u003eVilon enters the cell and accumulates in the nucleus, where it exerts effects at the \u003cstrong data-start=\"1329\" data-end=\"1349\"\u003eepigenetic level\u003c\/strong\u003e. Studies suggest it promotes \u003cstrong data-start=\"1379\" data-end=\"1417\"\u003echromatin deheterochromatinization\u003c\/strong\u003e—that is, it loosens tightly packed DNA within the nucleus, enhancing accessibility to transcriptional machinery. This results in:\u003c\/p\u003e\n\u003cul data-start=\"1549\" data-end=\"1728\"\u003e\n\u003cli data-start=\"1549\" data-end=\"1630\"\u003e\n\u003cp data-start=\"1551\" data-end=\"1630\"\u003e\u003cstrong data-start=\"1551\" data-end=\"1585\"\u003eReactivation of silenced genes\u003c\/strong\u003e (including ribosomal RNA and cytokine genes)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1631\" data-end=\"1660\"\u003e\n\u003cp data-start=\"1633\" data-end=\"1660\"\u003e\u003cstrong data-start=\"1633\" data-end=\"1660\"\u003eEnhanced mRNA synthesis\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1661\" data-end=\"1728\"\u003e\n\u003cp data-start=\"1663\" data-end=\"1728\"\u003eIncreased \u003cstrong data-start=\"1673\" data-end=\"1697\"\u003eprotein biosynthesis\u003c\/strong\u003e in senescent or stressed cells\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1730\" data-end=\"1820\"\u003eThis chromatin remodeling is central to Vilon’s proposed \u003cstrong data-start=\"1787\" data-end=\"1819\"\u003ecell-rejuvenating properties\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-start=\"1822\" data-end=\"1861\"\u003e\u003cstrong data-start=\"1826\" data-end=\"1861\"\u003e2.2. Gene Expression Modulation\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1863\" data-end=\"1959\"\u003eVilon has been shown to increase the expression of key immune and regenerative genes, including:\u003c\/p\u003e\n\u003cul data-start=\"1961\" data-end=\"2218\"\u003e\n\u003cli data-start=\"1961\" data-end=\"2035\"\u003e\n\u003cp data-start=\"1963\" data-end=\"2035\"\u003e\u003cstrong data-start=\"1963\" data-end=\"1971\"\u003eIL-2\u003c\/strong\u003e (a key regulator of T-cell proliferation and immune competence)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2036\" data-end=\"2102\"\u003e\n\u003cp data-start=\"2038\" data-end=\"2102\"\u003e\u003cstrong data-start=\"2038\" data-end=\"2072\"\u003eGenes for ribosomal components\u003c\/strong\u003e (enhancing protein synthesis)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2103\" data-end=\"2218\"\u003e\n\u003cp data-start=\"2105\" data-end=\"2218\"\u003e\u003cstrong data-start=\"2105\" data-end=\"2130\"\u003eCell cycle regulators\u003c\/strong\u003e, which may explain effects on proliferation and regeneration in aged or damaged tissues\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2220\" data-end=\"2335\"\u003eThese effects are thought to mimic some aspects of \u003cstrong data-start=\"2271\" data-end=\"2298\"\u003ethymic hormone activity\u003c\/strong\u003e, especially in aging immune systems.\u003c\/p\u003e\n\u003ch3 data-start=\"2337\" data-end=\"2392\"\u003e\u003cstrong data-start=\"2341\" data-end=\"2392\"\u003e2.3. Antioxidant and Anti-Inflammatory Activity\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"2394\" data-end=\"2632\"\u003e\n\u003cli data-start=\"2394\" data-end=\"2464\"\u003e\n\u003cp data-start=\"2396\" data-end=\"2464\"\u003eReduces \u003cstrong data-start=\"2404\" data-end=\"2424\"\u003eoxidative stress\u003c\/strong\u003e markers (e.g., ROS, lipid peroxidation)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2465\" data-end=\"2531\"\u003e\n\u003cp data-start=\"2467\" data-end=\"2531\"\u003eEnhances \u003cstrong data-start=\"2476\" data-end=\"2498\"\u003eantioxidant enzyme\u003c\/strong\u003e expression (e.g., SOD, catalase)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2532\" data-end=\"2632\"\u003e\n\u003cp data-start=\"2534\" data-end=\"2632\"\u003eModulates \u003cstrong data-start=\"2544\" data-end=\"2565\"\u003ecytokine cascades\u003c\/strong\u003e, including downregulation of pro-inflammatory mediators like TNF-α\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2634\" data-end=\"2755\"\u003eThese mechanisms support its potential use in \u003cstrong data-start=\"2680\" data-end=\"2704\"\u003eage-related diseases\u003c\/strong\u003e, chronic inflammation, and degenerative disorders.\u003c\/p\u003e\n\u003chr data-start=\"2757\" data-end=\"2760\"\u003e\n\u003ch2 data-start=\"2762\" data-end=\"2814\"\u003e\u003cstrong data-start=\"2765\" data-end=\"2814\"\u003e3. Preclinical and Clinical Research Findings\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-start=\"2816\" data-end=\"2866\"\u003e\u003cstrong data-start=\"2820\" data-end=\"2866\"\u003e3.1. Geroprotective and Anti-Aging Effects\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2868\" data-end=\"2901\"\u003eAnimal studies have demonstrated:\u003c\/p\u003e\n\u003cul data-start=\"2903\" data-end=\"3135\"\u003e\n\u003cli data-start=\"2903\" data-end=\"2954\"\u003e\n\u003cp data-start=\"2905\" data-end=\"2954\"\u003e\u003cstrong data-start=\"2905\" data-end=\"2927\"\u003eLifespan extension\u003c\/strong\u003e of up to 25–30% in rodents\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2955\" data-end=\"2999\"\u003e\n\u003cp data-start=\"2957\" data-end=\"2999\"\u003e\u003cstrong data-start=\"2957\" data-end=\"2999\"\u003eDelayed onset of age-associated tumors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3000\" data-end=\"3064\"\u003e\n\u003cp data-start=\"3002\" data-end=\"3064\"\u003e\u003cstrong data-start=\"3002\" data-end=\"3064\"\u003eImproved neuromuscular coordination and locomotor activity\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3065\" data-end=\"3135\"\u003e\n\u003cp data-start=\"3067\" data-end=\"3135\"\u003e\u003cstrong data-start=\"3067\" data-end=\"3122\"\u003ePreservation of thymic structure and immune profile\u003c\/strong\u003e in aged mice\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3137\" data-end=\"3257\"\u003eThese results have been used to justify Vilon’s inclusion in anti-aging protocols in Russia and parts of Eastern Europe.\u003c\/p\u003e\n\u003ch3 data-start=\"3259\" data-end=\"3313\"\u003e\u003cstrong data-start=\"3263\" data-end=\"3313\"\u003e3.2. Immunostimulatory and Restorative Effects\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"3315\" data-end=\"3343\"\u003eVilon has shown efficacy in:\u003c\/p\u003e\n\u003cul data-start=\"3345\" data-end=\"3570\"\u003e\n\u003cli data-start=\"3345\" data-end=\"3413\"\u003e\n\u003cp data-start=\"3347\" data-end=\"3413\"\u003e\u003cstrong data-start=\"3347\" data-end=\"3376\"\u003eRestoring immune function\u003c\/strong\u003e in aged and immunosuppressed animals\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3414\" data-end=\"3472\"\u003e\n\u003cp data-start=\"3416\" data-end=\"3472\"\u003eStimulating \u003cstrong data-start=\"3428\" data-end=\"3472\"\u003eT-cell differentiation and proliferation\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3473\" data-end=\"3570\"\u003e\n\u003cp data-start=\"3475\" data-end=\"3570\"\u003eEnhancing \u003cstrong data-start=\"3485\" data-end=\"3507\"\u003ecytokine signaling\u003c\/strong\u003e in response to immune challenge (e.g., vaccination, infection)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3572\" data-end=\"3637\"\u003eClinical studies (primarily in Russia) have reported benefits in:\u003c\/p\u003e\n\u003cul data-start=\"3639\" data-end=\"3800\"\u003e\n\u003cli data-start=\"3639\" data-end=\"3683\"\u003e\n\u003cp data-start=\"3641\" data-end=\"3683\"\u003e\u003cstrong data-start=\"3641\" data-end=\"3661\"\u003eElderly patients\u003c\/strong\u003e with immunosenescence\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3684\" data-end=\"3719\"\u003e\n\u003cp data-start=\"3686\" data-end=\"3719\"\u003e\u003cstrong data-start=\"3686\" data-end=\"3719\"\u003ePostoperative immune recovery\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3720\" data-end=\"3800\"\u003e\n\u003cp data-start=\"3722\" data-end=\"3800\"\u003e\u003cstrong data-start=\"3722\" data-end=\"3750\"\u003eChronic viral infections\u003c\/strong\u003e, including hepatitis and herpesvirus reactivation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"3802\" data-end=\"3849\"\u003e\u003cstrong data-start=\"3806\" data-end=\"3849\"\u003e3.3. Antitumor and Oncostatic Potential\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"3851\" data-end=\"4069\"\u003e\n\u003cli data-start=\"3851\" data-end=\"3915\"\u003e\n\u003cp data-start=\"3853\" data-end=\"3915\"\u003eDecreased incidence of \u003cstrong data-start=\"3876\" data-end=\"3901\"\u003espontaneous neoplasms\u003c\/strong\u003e in aging mice\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3916\" data-end=\"3982\"\u003e\n\u003cp data-start=\"3918\" data-end=\"3982\"\u003eInhibition of tumor growth in transplantable murine tumor models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3983\" data-end=\"4069\"\u003e\n\u003cp data-start=\"3985\" data-end=\"4069\"\u003eSuggested enhancement of \u003cstrong data-start=\"4010\" data-end=\"4044\"\u003eimmune surveillance mechanisms\u003c\/strong\u003e (e.g., NK cell activity)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4071\" data-end=\"4169\"\u003eThough preclinical data are compelling, controlled human trials in oncology are currently lacking.\u003c\/p\u003e\n\u003chr data-start=\"4171\" data-end=\"4174\"\u003e\n\u003ch2 data-start=\"4176\" data-end=\"4239\"\u003e\u003cstrong data-start=\"4179\" data-end=\"4239\"\u003e4. Clinical Applications (Investigational and Off-label)\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"4241\" data-end=\"4352\"\u003eWhile not approved as a drug in the EU or US, Vilon is investigated or used (off-label or as a supplement) for:\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_16hzy_1\"\u003e\n\u003cdiv class=\"_tableWrapper_16hzy_14 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"4354\" data-end=\"4817\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"4354\" data-end=\"4384\"\u003e\n\u003ctr data-start=\"4354\" data-end=\"4384\"\u003e\n\u003cth data-start=\"4354\" data-end=\"4367\" data-col-size=\"md\"\u003eIndication\u003c\/th\u003e\n\u003cth data-start=\"4367\" data-end=\"4384\" data-col-size=\"md\"\u003eProposed Role\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"4417\" data-end=\"4817\"\u003e\n\u003ctr data-start=\"4417\" data-end=\"4501\"\u003e\n\u003ctd data-start=\"4417\" data-end=\"4466\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"4419\" data-end=\"4465\"\u003eImmunodeficiency (age-related, iatrogenic)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4466\" data-end=\"4501\" data-col-size=\"md\"\u003eImmune recovery, T-cell support\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4502\" data-end=\"4548\"\u003e\n\u003ctd data-start=\"4502\" data-end=\"4527\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"4504\" data-end=\"4526\"\u003eChronic infections\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4527\" data-end=\"4548\" data-col-size=\"md\"\u003eImmunoenhancement\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4549\" data-end=\"4633\"\u003e\n\u003ctd data-start=\"4549\" data-end=\"4595\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"4551\" data-end=\"4594\"\u003ePost-radiation and chemotherapy support\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4595\" data-end=\"4633\" data-col-size=\"md\"\u003eProtection of hematopoietic system\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4634\" data-end=\"4723\"\u003e\n\u003ctd data-start=\"4634\" data-end=\"4672\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"4636\" data-end=\"4671\"\u003eGeriatric and frailty syndromes\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4672\" data-end=\"4723\" data-col-size=\"md\"\u003eImprovement in vitality and systemic resilience\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4724\" data-end=\"4817\"\u003e\n\u003ctd data-start=\"4724\" data-end=\"4761\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"4726\" data-end=\"4760\"\u003ePreventive anti-aging regimens\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4761\" data-end=\"4817\" data-col-size=\"md\"\u003eEpigenetic reprogramming, oxidative stress reduction\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"sticky end-(--thread-content-margin) h-0 self-end select-none\"\u003e\n\u003cdiv class=\"absolute end-0 flex items-end\"\u003e\u003cspan class=\"\" data-state=\"closed\"\u003e\u003cbutton class=\"bg-token-bg-primary hover:bg-token-bg-tertiary text-token-text-secondary my-1 rounded-sm p-1 transition-opacity group-[:not(:hover):not(:focus-within)]:pointer-events-none group-[:not(:hover):not(:focus-within)]:opacity-0\"\u003e\u003csvg width=\"24\" height=\"24\" viewbox=\"0 0 24 24\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"icon-md-heavy\"\u003e\u003cpath fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M7 5C7 3.34315 8.34315 2 10 2H19C20.6569 2 22 3.34315 22 5V14C22 15.6569 20.6569 17 19 17H17V19C17 20.6569 15.6569 22 14 22H5C3.34315 22 2 20.6569 2 19V10C2 8.34315 3.34315 7 5 7H7V5ZM9 7H14C15.6569 7 17 8.34315 17 10V15H19C19.5523 15 20 14.5523 20 14V5C20 4.44772 19.5523 4 19 4H10C9.44772 4 9 4.44772 9 5V7ZM5 9C4.44772 9 4 9.44772 4 10V19C4 19.5523 4.44772 20 5 20H14C14.5523 20 15 19.5523 15 19V10C15 9.44772 14.5523 9 14 9H5Z\" fill=\"currentColor\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003c\/button\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"4819\" data-end=\"4822\"\u003e\n\u003ch2 data-start=\"4824\" data-end=\"4876\"\u003e\u003cstrong data-start=\"4827\" data-end=\"4876\"\u003e5. Safety, Pharmacokinetics, and Tolerability\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-start=\"4878\" data-end=\"4905\"\u003e\u003cstrong data-start=\"4882\" data-end=\"4905\"\u003e5.1. Safety Profile\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"4907\" data-end=\"5075\"\u003e\n\u003cli data-start=\"4907\" data-end=\"4974\"\u003e\n\u003cp data-start=\"4909\" data-end=\"4974\"\u003eExcellent tolerability in rodents and human observational cohorts\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4975\" data-end=\"5017\"\u003e\n\u003cp data-start=\"4977\" data-end=\"5017\"\u003eNo mutagenicity or genotoxicity reported\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5018\" data-end=\"5075\"\u003e\n\u003cp data-start=\"5020\" data-end=\"5075\"\u003eNo evidence of immunogenicity or allergic sensitization\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"5077\" data-end=\"5106\"\u003e\u003cstrong data-start=\"5081\" data-end=\"5106\"\u003e5.2. Pharmacokinetics\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"5108\" data-end=\"5432\"\u003e\n\u003cli data-start=\"5108\" data-end=\"5175\"\u003e\n\u003cp data-start=\"5110\" data-end=\"5175\"\u003e\u003cstrong data-start=\"5110\" data-end=\"5128\"\u003eAdministration\u003c\/strong\u003e: Intramuscular, sublingual, or oral (capsules)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5176\" data-end=\"5272\"\u003e\n\u003cp data-start=\"5178\" data-end=\"5272\"\u003e\u003cstrong data-start=\"5178\" data-end=\"5197\"\u003eBioavailability\u003c\/strong\u003e: Oral bioavailability is limited; injection preferred for systemic effects\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5273\" data-end=\"5348\"\u003e\n\u003cp data-start=\"5275\" data-end=\"5348\"\u003e\u003cstrong data-start=\"5275\" data-end=\"5289\"\u003eMetabolism\u003c\/strong\u003e: Degraded by peptidases into native amino acids (Lys, Glu)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5349\" data-end=\"5432\"\u003e\n\u003cp data-start=\"5351\" data-end=\"5432\"\u003e\u003cstrong data-start=\"5351\" data-end=\"5364\"\u003eHalf-life\u003c\/strong\u003e: Short (minutes), but epigenetic effects may persist for days\/weeks\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5434\" data-end=\"5437\"\u003e\n\u003ch2 data-start=\"5439\" data-end=\"5481\"\u003e\u003cstrong data-start=\"5442\" data-end=\"5481\"\u003e6. Regulatory and Commercial Status\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-start=\"5483\" data-end=\"5749\"\u003e\n\u003cli data-start=\"5483\" data-end=\"5554\"\u003e\n\u003cp data-start=\"5485\" data-end=\"5554\"\u003e\u003cstrong data-start=\"5485\" data-end=\"5505\"\u003eNot FDA-approved\u003c\/strong\u003e in the United States or EMA-authorized in Europe\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5555\" data-end=\"5653\"\u003e\n\u003cp data-start=\"5557\" data-end=\"5653\"\u003eRegistered as a \u003cstrong data-start=\"5573\" data-end=\"5620\"\u003epeptide supplement or therapeutic in Russia\u003c\/strong\u003e, Ukraine, and some CIS countries\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5654\" data-end=\"5749\"\u003e\n\u003cp data-start=\"5656\" data-end=\"5749\"\u003eAvailable as capsules or injectable vials, primarily for \u003cstrong data-start=\"5713\" data-end=\"5749\"\u003eresearch or private clinical use\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"5751\" data-end=\"5878\"\u003eGiven the lack of large, international Phase III clinical trials, Vilon remains \u003cstrong data-start=\"5831\" data-end=\"5845\"\u003eunapproved\u003c\/strong\u003e in major pharmaceutical markets.\u003c\/p\u003e\n\u003chr data-start=\"5880\" data-end=\"5883\"\u003e\n\u003ch2 data-start=\"5885\" data-end=\"5905\"\u003e\u003cstrong data-start=\"5888\" data-end=\"5905\"\u003e7. Conclusion\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"5907\" data-end=\"6417\"\u003e\u003cstrong data-start=\"5907\" data-end=\"5926\"\u003eVilon (Lys-Glu)\u003c\/strong\u003e represents an intriguing category of \u003cstrong data-start=\"5964\" data-end=\"5999\"\u003eshort-chain regulatory peptides\u003c\/strong\u003e with multifaceted biological effects. Its mechanisms—epigenetic modulation, immunostimulation, antioxidant action—support its investigation for \u003cstrong data-start=\"6144\" data-end=\"6182\"\u003eaging, immunity, cancer prevention\u003c\/strong\u003e, and \u003cstrong data-start=\"6188\" data-end=\"6213\"\u003ecellular rejuvenation\u003c\/strong\u003e. Preclinical data are robust and promising, but \u003cstrong data-start=\"6262\" data-end=\"6307\"\u003erigorous, placebo-controlled human trials\u003c\/strong\u003e are needed to fully validate its therapeutic potential and define optimal indications, dosages, and regimens.\u003c\/p\u003e\n\u003chr data-start=\"6419\" data-end=\"6422\"\u003e\n\u003ch2 data-start=\"6424\" data-end=\"6445\"\u003e\u003cstrong data-start=\"6427\" data-end=\"6445\"\u003eKey References\u003c\/strong\u003e\u003c\/h2\u003e\n\u003col data-start=\"6447\" data-end=\"7096\"\u003e\n\u003cli data-start=\"6447\" data-end=\"6603\"\u003e\n\u003cp data-start=\"6450\" data-end=\"6603\"\u003e\u003cstrong data-start=\"6450\" data-end=\"6476\"\u003eAnisimov, V. N. et al.\u003c\/strong\u003e (2001). \u003cem data-start=\"6485\" data-end=\"6548\"\u003eVilon increases lifespan and reduces tumor frequency in mice.\u003c\/em\u003e Mechanisms of Ageing and Development, 122(1), 41–68.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6604\" data-end=\"6747\"\u003e\n\u003cp data-start=\"6607\" data-end=\"6747\"\u003e\u003cstrong data-start=\"6607\" data-end=\"6631\"\u003eKhavinson, V. et al.\u003c\/strong\u003e (2013). \u003cem data-start=\"6640\" data-end=\"6705\"\u003eShort peptides regulate gene expression and increase life span.\u003c\/em\u003e Advances in Gerontology, 3(3), 497–502.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6748\" data-end=\"6900\"\u003e\n\u003cp data-start=\"6751\" data-end=\"6900\"\u003e\u003cstrong data-start=\"6751\" data-end=\"6773\"\u003eLezhava, T. et al.\u003c\/strong\u003e (2004). \u003cem data-start=\"6782\" data-end=\"6834\"\u003eChromatin activation by Vilon in aged lymphocytes.\u003c\/em\u003e Bulletin of Experimental Biology and Medicine, 137(4), 407–410.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6901\" data-end=\"6980\"\u003e\n\u003cp data-start=\"6904\" data-end=\"6980\"\u003e\u003cstrong data-start=\"6904\" data-end=\"6921\"\u003eCore Peptides\u003c\/strong\u003e. (2022). \u003cem data-start=\"6931\" data-end=\"6978\"\u003eVilon peptide and immune regulation research.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6981\" data-end=\"7096\"\u003e\n\u003cp data-start=\"6984\" data-end=\"7096\"\u003e\u003cstrong data-start=\"6984\" data-end=\"7040\"\u003eKhavinson Institute of Bioregulation and Gerontology\u003c\/strong\u003e. (2018). \u003cem data-start=\"7050\" data-end=\"7096\"\u003ePeptide bioregulators in geriatric medicine.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684859441490,"sku":null,"price":50.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/Vilon_20mg.png?v=1770834897","url":"https:\/\/sciencepeptideslab.com\/products\/vilon-5mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}